Founders From the Incumbent: An Asset and a Liability

← Back to All Insights

The strongest domain expertise on a cap table often arrives with the longest legal shadow.

A founding team out of the category leader — the ex-Medtronic regulatory lead, the ex-Boston Scientific design engineer, the diagnostics team from the reference-lab incumbent — is one of the most attractive signals in early-stage medtech. It is also one of the most under-examined risks. The same résumé that de-risks execution can hand a competitor's lawyers a roadmap. Underwriting only the upside ("great team") or only the downside ("litigation risk") both misread the situation. The job is to price both.

The asset is real, and it's under-credited

Operator knowledge from an incumbent is not interchangeable with a strong CV. A team that has actually shepherded a Class III device through PMA knows where the FDA conversation gets hard, how a design-history file has to be built to survive an audit, and where manufacturing scale-up quietly breaks. They carry KOL relationships and a felt sense of how a market adopts. First-time founders can be brilliant and still spend two years learning what this team already knows in their hands. That head start is a legitimate value driver, and standard diligence tends to reduce it to a bullet point.

The liability is four exposures a competitor knows how to use

1. Invention ownership

Most employment agreements assign inventions conceived during employment to the employer. If the core idea was conceived — or reduced to practice — while a founder was still at the prior company, ownership of the startup's foundational IP is contestable. The diligence questions are concrete: when and where was the idea conceived, and is there documentation that establishes it independently of the prior employer's time and resources?

2. Trade secrets

The federal Defend Trade Secrets Act of 2016 gives a former employer a powerful civil claim, and "inevitable disclosure" theories argue that a departing employee cannot help but use what they know. A device startup built by ex-competitor engineers is a natural target — the suit does not have to win to be existential, because the threat alone can freeze a financing or a deal.

3. Non-competes and non-solicits

Enforceability is now entirely a matter of state law. The FTC's attempted nationwide ban was struck down in federal court and formally removed from the Code of Federal Regulations effective February 12, 2026, so there is no federal backstop. California voids employee non-competes outright (Business & Professions Code §16600); most other states enforce "reasonable" ones; and several 2026 state laws — Tennessee, Utah, Virginia, Washington — have just moved the lines again, often with healthcare-specific carve-outs. The founder's state of residence, and the prior employer's, can change the answer entirely.

4. Provenance and clean-room hygiene

Did the team build fresh, or carry over documents, designs, source code, or customer lists? A disciplined clean-room process — documented independent development, no imported files, counsel-reviewed at formation — is the difference between a defensible startup and a lawsuit waiting for a trigger.

Diligencing both sides

• Read the founders' invention-assignment and confidentiality agreements from the prior employer — not just their LinkedIn tenure.
• Establish the conception timeline for the core IP, with documentation independent of the prior job.
• Confirm a clean-room formation process and whether counsel ran a freedom-to-operate and trade-secret review.
• Check non-compete enforceability against the relevant states, post-FTC-rule.
• Look at the prior employer's litigation history — some incumbents reliably sue departing teams; that pattern is a risk factor in itself.

An incumbent pedigree is simultaneously the best reason to believe in a team and the clearest place a deal can be blown up. Both facts are true at once, and a serious diligence read prices both.

At Vantage, this is a deliberately dual read: the Team assessment credits real operator depth from a comparable company, while the Legal & IP risk-flag register surfaces the invention-ownership, trade-secret, and non-compete exposures that come attached — each flag cited to a source, framed as a question for your counsel, and explicitly not legal advice.

Price the Team — and the Shadow

Our diligence credits real operator depth and surfaces the IP, trade-secret, and non-compete exposures that come with an incumbent pedigree — every flag cited, framed for your counsel, and never fabricated.

Schedule a Discovery Call See a Sample Deliverable